AdAlta

Ticker 1AD

Exchange ASX More
Industry Biotechnology More
Sector Healthcare More

1-10 Employees
Based in Melbourne, Australia

AdAlta is the pioneer of a novel technology platform that mimics the shape and engineers key stability features of the antigen binding domain of shark antibodies into human proteins to create unique compounds, known as i-bodies, for therapeutic intervention in disease.

Visit website

REPORT RATINGS

4.7 / 5.0 (87)

AdAlta reports have an aggregate usefulness score of 4.7 based on 87 reviews.

AdAlta